nuvaring and Sexual-Dysfunction--Physiological

To assess sexual function of first-time users of the contraceptive ring and contraceptive patch.. Open-label randomized trial.. Multicenter study.. A total of 500 healthy, premenopausal, nonpregnant women who had recently used combined oral contraceptives.. Contraceptive ring vs. contraceptive patch.. Subjects completed the Female Sexual Function Index (FSFI) before randomization to the study product and after 3 months. Unadjusted and adjusted changes in total and domain FSFI scores from baseline to exit were compared between treatment groups using linear regression (intention-to-treat approach).. Final adjusted mean total FSFI scores increased by 0.32 points in the patch group and decreased by 0.74 points in the ring group. Subjects in the ring group had worsening scores in the areas of arousal (score change -0.169 ring vs 0.010 patch), lubrication (score change -0.202 ring vs. 0.031 patch), and pain (score change -0.162 ring vs. 0.182 patch).. Among recent combined oral contraceptive users, slight decrements in sexual function scores were noted with contraceptive ring use overall and in several domains of sexual functioning, whereas slight increases were noted with patch use. However, for both products, these changes are not likely to be clinically significant.

Topics: Administration, Cutaneous; Administration, Intravaginal; Adult; Contraception; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Linear Models; Male; Patient Satisfaction; Prospective Studies; Sexual Behavior; Sexual Dysfunction, Physiological; Sexual Partners; Surveys and Questionnaires; Time Factors; United States; Young Adult

Oral contraceptives could induce mood changes. As far as our knowledge, there are no studies in literature that have examined the role of vaginal contraception in self-perceived body image.. To evaluate the effects of intravaginal contraception on weight gain and perceived body image in relation with the Beck's Depression Inventory questionnaire (BDI) and the McCoy Female Sexuality Questionnaire (MFSQ).. Twenty-one adult (18-35 years old) eumenorrheic (menstrual cycle of 25-35 days), lean (body mass index - BMI - of 19-25 kg/m. BMI, FRS, MFSQ and BDI.. After 6 months of therapy with NuvaRing®, both body weight (60.0 ± 8.3; p = 0.050) and BMI (22.1 ± 3.1; p = 0.028) slightly, but statistically, increased. FRS and BDI showed no differences after the vaginal contraception. Hormonal contraception was associated with a significant decrease in the two-factor Italian MFSQ score.. Vaginal ring seems a good alternative to other hormonal contraceptive not significantly altering the female sexuality and not influencing the FRS and BDI.

Topics: Adolescent; Adult; Body Dysmorphic Disorders; Body Mass Index; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Health Knowledge, Attitudes, Practice; Humans; Italy; Overweight; Pilot Projects; Prospective Studies; Psychiatric Status Rating Scales; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Weight Gain; Young Adult